Skip to main content
Red White Bloom Brands Inc. logo

Red White Bloom Brands Inc. — Investor Relations & Filings

Ticker · RWB ISIN · CA75704R1010 LEI · 529900BC9FVPGS7JGF22 CSE Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country CA Canada
Listing CSE RWB

About Red White Bloom Brands Inc.

https://www.redwhitebloom.com/

Red White & Bloom Brands Inc. is a multi-jurisdictional cannabis operator focused on manufacturing and distributing a diverse portfolio of premium cannabis products and accessories. The company employs a "house of brands" strategy, offering a full suite of high-quality cannabis-based products, including those containing THC and CBD, such as recreational items and skincare. RWB utilizes proprietary product development capabilities and emphasizes vertical integration, controlling the entire process from cultivation ("seed") through to distribution and sale, ensuring product quality and consistency across its operations.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 90% confidence The document is a brief notice from the transfer agent to regulators and exchanges announcing the upcoming Annual General Meeting’s record dates and related procedural details. It does not contain voting results (which would be DVA), proxy materials (PSI), or the AGM materials themselves (AGM-R). It serves as a regulatory announcement rather than the actual report, fitting the Regulatory Filings (RNS) category.
2026-05-22 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2026-05-01 English
Audited annual financial statements – English.pdf
Regulatory Filings
2026-05-01 English
Annual MD&A - English.pdf
Regulatory Filings
2026-05-01 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2026-05-01 English
Material change report - English.pdf
M&A Activity Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed under Canadian securities regulations disclosing the selection of the company’s subsidiary as the successful bidder in a court-supervised sale and investment solicitation process (a share purchase acquisition) subject to court approval and closing conditions. This constitutes an M&A announcement regarding the acquisition of Ayurcann’s assets and business. It is not an earnings, management change, dividend or governance report, but rather a transaction notice related to a takeover bid/acquisition. Therefore, it fits the M&A Activity category (Code: TAR).
2026-04-21 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.